[{"data":1,"prerenderedAt":168},["ShallowReactive",2],{"story-18361-cn":3},{"id":4,"slug":5,"slugs":5,"currentSlug":5,"title":6,"subtitle":7,"coverImagesSmall":8,"coverImages":9,"content":29,"questions":30,"relatedArticles":43,"body_color":166,"card_color":167},"18361",null,"Biotech Investment Surge: $450M Raised in Medical Innovation","- Rakuten Medical Leads $100M Series F in Cancer Research Breakthrough",[],[10,11,12,13,14,15,16,17,18,19,20,21,22,23,24,25,26,27,17,28],"https://endpoints.news/wp-content/uploads/2026/01/Soley-Therapeutics-co-founders.jpg","https://endpoints.news/wp-content/uploads/2023/03/Mathai-Mammen-Fog-Pharma-feature.jpg","https://cdn.zonebourse.com/static/resize/1200/675//images/reuters/2025-01-10T083825Z_1_LYNXMPEL0908B_RTROPTP_3_MARKETS-EUROPE-STOCKS.JPG","https://qtxasset.com/cdn-cgi/image/w=384,h=216,f=auto,fit=crop,g=0.5x0.5/https://qtxasset.com/quartz/qcloud5/media/image/Space%20rocket.jpg?VersionId=Qo9JOC.ChL2aqZTohrht8uMBj9h2eGLE","https://s.yimg.com/ny/api/res/1.2/PrrlhpWfP6niYzQ7hfafnQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTY0MDtoPTUzNg--/https://media.zenfs.com/en/business-wire.com/aca97b3e7972539528de19cb47512f9e","https://s.yimg.com/ny/api/res/1.2/W6Af9jdVy09PxaIfxyFT3A--/YXBwaWQ9aGlnaGxhbmRlcjt3PTY0MDtoPTI4OA--/https://media.zenfs.com/en/business-wire.com/7194845770a18614ae4bb95d8e1fb89a","https://cdn.pulse2.com/cdn/2026/01/Parabilis-Medicines-Logo.jpeg","https://images.wsj.net/im-58996945?width=700&height=466","https://qtxasset.com/cdn-cgi/image/w=384,h=216,f=auto,fit=crop,g=0.5x0.5/https://qtxasset.com/quartz/qcloud5/media/image/GettyImages-474045836.jpg?VersionId=ZrON.9gb_kdB6Eg3v6PzrOmMBLN2o4F4","https://qtxasset.com/quartz/qcloud5/media/image/Space%20rocket.jpg?VersionId=Qo9JOC.ChL2aqZTohrht8uMBj9h2eGLE","https://cdn.pulse2.com/cdn/2026/01/Rakuten-Medical.jpg","https://endpoints.news/wp-content/uploads/2021/07/Hiroshi-Mickey-Mikitani-Rakuten-tile-AP-scaled.jpg","https://www.finsmes.com/wp-content/uploads/2016/07/cancer.jpg","https://qtxasset.com/cdn-cgi/image/w=384,h=216,f=auto,fit=crop,g=0.5x0.5/https://qtxasset.com/quartz/qcloud5/media/image/GettyImages-1184397025.jpg?VersionId=PiEcxw5eJYhuY_D50kLC49ppTNu8owcl","https://imgproxy.divecdn.com/DqAfdIEC7iiLkCwNWR5wCEl8U5vRlC5gC234oiqfRoc/g:ce/rs:fill:1200:675:1/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9NYXRoYWlNYW1tZW4tOC5qcGc=.webp","https://static.biospace.com/dims4/default/8af57f4/2147483647/strip/true/crop/3000x1689+0+156/resize/1000x563!/quality/90/?url=https%3A%2F%2Fstatic.biospace.com%2F9f%2F5e%2F3311e1b443ada372e79d3e2fb48c%2Fistock-2161080785.jpg","https://insights.citeline.com/resizer/v2/SDNUC6JU3VLANCGYXXII3MD4RM.jpg?smart=true&auth=1f97b31814c58a50563d331dbf8611b35643133d0d09417d0a1f0b61aff9eabd&width=700&height=394","https://www.statnews.com/wp-content/uploads/2020/01/money-bills-spending-645x645.jpeg","https://media.bizj.us/view/img/12480724/mathaimammen-8*900xx4200-2367-0-208.jpg","The biotech investment landscape is experiencing a transformative moment in early 2025, characterized by substantial venture capital infusions targeting precision medical technologies. Rakuten Medical's $100 million Series F funding represents a critical milestone in cancer treatment innovation, signaling robust investor confidence in targeted therapeutic approaches.\n\nThe fundraising landscape reveals strategic investment patterns across oncology, cardiovascular, and precision medicine domains. Rakuten Medical's funding specifically supports a global Phase 3 trial for head and neck cancer treatments, combining ASP-1929 with Merck's Keytruda. This approach demonstrates the growing trend of combination therapies and targeted molecular interventions.\n\nKey investment highlights include Soley Therapeutics' remarkable $200 million Series C round, focusing on AI and computer vision for cell stress analysis, and additional significant investments in Corsera Health ($80M) and Poplar Therapeutics ($50M). These funding rounds underscore a broader industry shift towards technology-driven medical research, with investors prioritizing innovative approaches that leverage advanced computational techniques.\n\nThe convergence of AI, computer vision, and precision medicine represents a critical inflection point for biotechnology investments. Investors are clearly signaling their belief in breakthrough technologies that can transform traditional treatment paradigms, particularly in oncology and rare disease research.",[31,34,37,40],{"title":32,"answer":33,"author":5,"avatar":5,"time":5},"Which medical research areas are attracting the most investment?","Oncology remains a primary focus, with significant investments in cancer research. Additionally, cardiovascular treatments, RNAi-based therapies, and food allergy research are attracting substantial venture capital, indicating a diverse and dynamic investment landscape.",{"title":35,"answer":36,"author":5,"avatar":5,"time":5},"What makes Rakuten Medical's $100M funding significant?","Rakuten Medical's funding supports a global Phase 3 trial for head and neck cancer treatments, combining innovative therapy ASP-1929 with Merck's Keytruda. This represents a strategic approach to combination therapies and demonstrates strong investor confidence in precision medical technologies.",{"title":38,"answer":39,"author":5,"avatar":5,"time":5},"How are AI and technology influencing biotech investments?","Investors are increasingly prioritizing companies like Soley Therapeutics that leverage AI, computer vision, and advanced computational techniques for medical research. The $200M Series C round for cell stress analysis highlights the growing intersection of technology and medical innovation.",{"title":41,"answer":42,"author":5,"avatar":5,"time":5},"What trends are emerging in medical research funding?","Key trends include increased investment in precision medicine, targeted molecular therapies, oncology research, and technologies that combine AI with medical research. Investors are showing strong interest in breakthrough approaches that can transform traditional treatment methods.",[44,49,54,58,62,66,70,74,78,83,87,91,95,99,103,106,110,114,118,122,126,130,134,138,142,146,150,154,158,162],{"id":45,"title":46,"source":47,"logo":21,"time":48},195091,"Rakuten Medical raises $100M for photoimmunotherapy platform","https://endpoints.news/rakuten-medical-raises-100m-for-photoimmunotherapy-platform/","3天前",{"id":50,"title":51,"source":52,"logo":12,"time":53},195090,"Sumitomo Mitsui Financial : SMBC�fs Investment in Rakuten Medical, Inc.","https://www.marketscreener.com/news/sumitomo-mitsui-financial-smbci-fs-investment-in-rakuten-medical-inc-ce7e59dcd088f722","2天前",{"id":55,"title":56,"source":57,"logo":5,"time":48},195093,"Rakuten Medical Raises $100 Million in Oversubscribed Series F to Accelerate Development Toward U.S. Regulatory Approval","https://rakuten-med.com/us/news/press-releases/2026/01/07/7929/",{"id":59,"title":60,"source":61,"logo":5,"time":48},195092,"Jim Breyer: Soley Therapeutics secures $200 million Series C funding","https://tradersunion.com/news/billionaires/show/1227567-soley-therapeutics-secures-funding/",{"id":63,"title":64,"source":65,"logo":23,"time":48},195095,"Soley secures $200M series C to take cell stress drug to clinic","https://www.fiercebiotech.com/biotech/soley-secures-200m-series-c-push-aml-cell-stress-drug-clinic",{"id":67,"title":68,"source":69,"logo":5,"time":48},195094,"Rakuten Medical Raises $100M in Series F Funding","https://www.finsmes.com/2026/01/rakuten-medical-raises-100m-in-series-f-funding.html",{"id":71,"title":72,"source":73,"logo":5,"time":53},200196,"Parabilis Medicines Announces Oversubscribed $305 Million Financing to Support Ongoing FOG-001 (zolucatetide) Clinical Development Across a Broad Range of Tumors and Advance Pioneering Pipeline and Helicon Platform","https://www.biospace.com/press-releases/parabilis-medicines-announces-oversubscribed-305-million-financing-to-support-ongoing-fog-001-zolucatetide-clinical-development-across-a-broad-range-of-tumors-and-advance-pioneering-pipeline-and-helicon-platform",{"id":75,"title":76,"source":77,"logo":17,"time":53},196634,"Rakuten Medical Raises $100 Million in Fundraising Round - WSJ","https://www.wsj.com/health/pharma/rakuten-medical-raises-100-million-in-fundraising-round-bc077d4c?gaa_at=eafs&gaa_n=AWEtsqdzcpvGVoon--vB8t9h-f1XvwkH_B-hj2UAoVMWSTfWO809HGzN3Vkw&gaa_ts=695fa311&gaa_sig=eHwREN_h9kAmiiLAaxcJOD0wZcPy57YB0uBQX5Z7J2gGRVtPcJ_uJQFIWGfU58xcyrQfQmz4sI0hfshw7iW0uQ%3D%3D",{"id":79,"title":80,"source":81,"logo":26,"time":82},200195,"Finance Watch: Biopharma Sets A Brisk VC Investment Pace Ahead Of J.P. Morgan","https://insights.citeline.com/scrip/business/financing/finance-watch/finance-watch-biopharma-sets-a-brisk-vc-investment-pace-ahead-of-jp-morgan-JYLNSO6EBFB43PGE7OJJMUNKPY/","1天前",{"id":84,"title":85,"source":86,"logo":25,"time":53},198892,"Parabilis Heads Biotech Fundraising Frenzy With $305M to Advance Cancer Drug","https://www.biospace.com/business/parabilis-heads-biotech-fundraising-frenzy-with-305m-to-advance-cancer-drug",{"id":88,"title":89,"source":90,"logo":5,"time":53},198891,"Parabilis reels in $305M in pursuit of 'undruggable' cancer targets","https://www.firstwordpharma.com/story/7048069",{"id":92,"title":93,"source":94,"logo":28,"time":53},199040,"$780M in funding announced at local biotechs in lead-up to JPMorgan conference","https://www.bizjournals.com/boston/news/2026/01/08/mass-vc-january-2026-jpmorgan.html",{"id":96,"title":97,"source":98,"logo":22,"time":53},198890,"Parabilis Medicines Raises $305M Series F Funding","https://www.finsmes.com/2026/01/parabilis-medicines-raises-305m-series-f-funding.html",{"id":100,"title":101,"source":102,"logo":24,"time":53},198889,"Parabilis, chasing ‘undruggable’ targets, nabs $305M amid VC funding blitz","https://www.biopharmadive.com/news/parabilis-financing-zolucatetide-beta-catenin-cancer-drug/809079/",{"id":104,"title":72,"source":105,"logo":15,"time":53},198888,"https://finance.yahoo.com/news/parabilis-medicines-announces-oversubscribed-305-120000657.html",{"id":107,"title":108,"source":109,"logo":5,"time":48},195097,"Soley bags $200M to pursue drug development based on cellular stress sensing","https://www.firstwordpharma.com/story/7047462",{"id":111,"title":112,"source":113,"logo":20,"time":48},195096,"Rakuten Medical: $100 Million Series F Raised To Accelerate U.S. Path For ASP-1929","https://pulse2.com/rakuten-medical-100-million-series-f/",{"id":115,"title":116,"source":117,"logo":10,"time":48},195231,"Exclusive: Soley emerges with $200M Series C and broad pipeline for 'stress clock'","https://endpoints.news/soley-emerges-with-200m-series-c-and-broad-pipeline-for-stress-clock/",{"id":119,"title":120,"source":121,"logo":14,"time":48},195098,"Soley Therapeutics Announces $200 Million Series C Financing to Propel Lead Oncology Programs into the Clinic and Scale Its Cell Stress Sensing Platform","https://finance.yahoo.com/news/soley-therapeutics-announces-200-million-130000432.html",{"id":123,"title":124,"source":125,"logo":17,"time":53},195230,"Rakuten Medical Raises $100 Million in Fundraising Round","https://www.wsj.com/health/pharma/rakuten-medical-raises-100-million-in-fundraising-round-bc077d4c?gaa_at=eafs&gaa_n=AWEtsqcEKIBziwjPj3lCE-E3ZvvQBcT5-x1eB_Bh5vkvitqQn9Ecp1t9Jelg&gaa_ts=695f68bf&gaa_sig=qfOlpXrNVpc_3hwmM3CnIjU8bcN8zDosq0rkQ3WNU7d7gOS64gioVoTVe5q-TWrC2T8hqmedvUhAxeYfX1QORw%3D%3D",{"id":127,"title":128,"source":129,"logo":5,"time":48},195233,"Rakuten lights path to 2028 FDA filing with fresh $100M raise","https://www.fiercebiotech.com/biotech/rakuten-lights-path-2028-fda-filing-fresh-100m-raise",{"id":131,"title":132,"source":133,"logo":5,"time":53},197654,"Series C - Soley Therapeutics","https://www.crunchbase.com/funding_round/soley-therapeutics-series-c--43364266",{"id":135,"title":136,"source":137,"logo":13,"time":53},198887,"Parabilis rockets ahead with $305M series F to 'upend the status quo' with tumor drug","https://www.fiercebiotech.com/biotech/parabilis-medicines-rockets-ahead-305m-fundraise-upend-status-quo",{"id":139,"title":140,"source":141,"logo":18,"time":48},195232,"Fierce Biotech Fundraising Tracker '26: Soley sees $200M series C; Rakuten rakes in $100M","https://www.fiercebiotech.com/biotech/fierce-biotech-fundraising-tracker-26",{"id":143,"title":144,"source":145,"logo":16,"time":53},198886,"Parabilis Medicines: $305 Million Series F Raised To Advance Zolucatetide Program And Helicon Peptide Platform","https://pulse2.com/parabilis-medicines-305-million-series-f/",{"id":147,"title":148,"source":149,"logo":5,"time":53},197652,"Soley Therapeutics Raises $200M in Series C Financing","https://www.finsmes.com/2026/01/soley-therapeutics-raises-200m-in-series-c-financing.html",{"id":151,"title":152,"source":153,"logo":19,"time":53},198885,"Parabilis Medicines","https://www.fiercebiotech.com/keyword/parabilis-medicines",{"id":155,"title":156,"source":157,"logo":11,"time":53},199039,"Parabilis gets $305M for quest to conquer ‘undruggable’ proteins after early success","https://endpoints.news/parabilis-gets-305m-to-tackle-undruggable-proteins/",{"id":159,"title":160,"source":161,"logo":5,"time":53},197653,"Wilson Sonsini Advises Soley Therapeutics on $200 Million Series C Financing","https://www.wsgr.com/en/insights/wilson-sonsini-advises-soley-therapeutics-on-dollar200-million-series-c-financing.html",{"id":163,"title":164,"source":165,"logo":27,"time":53},199038,"Parabilis Medicines raises $305 million as CEO warms to an IPO","https://www.statnews.com/2026/01/08/parabilis-medicines-biotech-investors-crossover/","#e89ffcff","#e89ffc4d",1768095063470]